Benactyzine

Source: Wikipedia, the free encyclopedia.
Benactyzine
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration		Oral
ATC code
  • none
Legal status
Legal status
  • BR: Class C1 (Other controlled substances)[1]
  • In general: ℞ (Prescription only)
Identifiers
  • 2-(diethylamino)ethyl hydroxy(diphenyl)acetate
JSmol)
  • O=C(OCCN(CC)CC)C(O)(c1ccccc1)c2ccccc2
  • InChI=1S/C20H25NO3/c1-3-21(4-2)15-16-24-19(22)20(23,17-11-7-5-8-12-17)18-13-9-6-10-14-18/h5-14,23H,3-4,15-16H2,1-2H3 checkY
  • Key:IVQOFBKHQCTVQV-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Benactyzine is an

FDA due to serious side effects.[2]

Its use for these indications was limited by

hallucinogenic effects.[2] "Large doses of benactyzine in normal subjects may produce a state resembling the action of mescaline or LSD."[3]

Brand names have included: Suavitil, Phebex, Phobex, Cedad, Cevanol, Deprol, Lucidil, Morcain, Nutinal, Parasan. While there was some tentative evidence of effectiveness when combined with meprobamate, with the medication no longer available it is not clinically important.[4]

History

Benactyzine was brought to market in the US in 1957 by Merck under the tradename, Suavitil.[5]

References

  1. ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. ^
    S2CID 23439533
    .
  3. ^ Fisher S (1959). Child Research In Psychopharmacology (1st ed.). Springfield, Illinois: Charles C Thomas Pub. p. 13.
  4. ISBN 978-1-58562-377-8
    .
  5. ISBN 978-1-317-94071-5
    .

External links
Retrieved from "https://en.wikipedia.org/w/index.php?title=Benactyzine&oldid=1171698454"